Key clinical point: Patients with psoriatic arthritis (PsA) who had nail psoriasis were older and had higher disease burden and lower quality of life (QoL) than those without nail psoriasis.
Major finding: Patients with vs. without nail psoriasis had a higher median age (48 vs. 46 years; P = .001), body mass index (29 vs. 28 kg/m2; P = .02), tender (P < .001) and swollen (P = .011) joint counts, and PsAQoL score (6 vs. 4; P = .001).
Study details: Findings are from a cross-sectional, multicenter study including 1,22 patients with PsA, of which 57.5% had nail psoriasis.
Disclosures: This study did not receive any funding. The authors declared no conflicts of interest.
Source: Cengiz G et al. The impact of nail psoriasis on disease activity, quality of life, and clinical variables in patients with psoriatic arthritis: A cross-sectional multicenter study. Int J Rheum Dis. 2022 (Sep 27). Doi:10.1111/1756-185X.14442